KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Equity Ratio (2016 - 2025)

Amgen (AMGN) has 17 years of Equity Ratio data on record, last reported at 0.1 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 49.36% year-over-year to 0.1; the TTM value through Dec 2025 reached 0.1, up 49.36%, while the annual FY2025 figure was 0.1, 49.36% up from the prior year.
  • Equity Ratio reached 0.1 in Q4 2025 per AMGN's latest filing, down from 0.11 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.15 in Q1 2021 and bottomed at 0.02 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.08, with a median of 0.07 recorded in 2023.
  • Peak YoY movement for Equity Ratio: plummeted 89.63% in 2022, then surged 289.55% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.11 in 2021, then plummeted by 48.68% to 0.06 in 2022, then rose by 14.1% to 0.06 in 2023, then decreased by 0.24% to 0.06 in 2024, then surged by 49.36% to 0.1 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.1 in Q4 2025, 0.11 in Q3 2025, and 0.08 in Q2 2025.